Restless legs syndrome in narcolepsy: a side effect of sodium oxybate?

Sleep Med. 2007 Mar;8(2):181-3. doi: 10.1016/j.sleep.2006.06.003. Epub 2007 Feb 1.

Abstract

Gamma-hydroxybutyrate (GHB) has re-emerged as a major treatment for narcolepsy. As dopaminergic transmission is clearly involved in the pathophysiology of restless legs syndrome (RLS), and GHB reduces dopamine release, one may hypothesize that RLS may occur in narcolepsy in the presence of GHB. We report a case of narcolepsy with a severe occurrence of typical RLS with GHB, symptoms never previously experienced by the subject and reversible after withdrawal.

Publication types

  • Case Reports

MeSH terms

  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Male
  • Middle Aged
  • Narcolepsy / drug therapy*
  • Restless Legs Syndrome / chemically induced*
  • Restless Legs Syndrome / diagnosis
  • Sodium Oxybate / therapeutic use*

Substances

  • Sodium Oxybate